Reported Earnings • Aug 01
Second quarter 2026 earnings released: EPS: US$0.052 (vs US$0.016 in 2Q 2025) Second quarter 2026 results: EPS: US$0.052 (up from US$0.016 in 2Q 2025). Revenue: US$110.8m (up 7.3% from 2Q 2025). Net income: US$20.0m (up 223% from 2Q 2025). Profit margin: 18% (up from 6.0% in 2Q 2025). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 31
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to Rp15,325, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 10x in the Chemicals industry in Indonesia. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • May 25
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to Rp15,125, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 11x in the Chemicals industry in Indonesia. Total returns to shareholders of 102% over the past three years. Declared Dividend • May 22
Dividend of Rp1.45 announced Shareholders will receive a dividend of Rp1.45. Ex-date: 29th May 2026 Payment date: 9th June 2026 Dividend yield will be 1.5%, which is higher than the industry average of 0.6%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (14% cash payout ratio). The dividend has increased by an average of 18% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend. Reported Earnings • May 05
First quarter 2026 earnings released: EPS: US$0.029 (vs US$0.015 in 1Q 2025) First quarter 2026 results: EPS: US$0.029 (up from US$0.015 in 1Q 2025). Revenue: US$99.9m (up 9.5% from 1Q 2025). Net income: US$11.1m (up 94% from 1Q 2025). Profit margin: 11% (up from 6.3% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 13% per year. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to Rp12,775, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 14x in the Chemicals industry in Indonesia. Total returns to shareholders of 61% over the past three years. Announcement • Apr 10
PT Unggul Indah Cahaya Tbk, Annual General Meeting, May 18, 2026 PT Unggul Indah Cahaya Tbk, Annual General Meeting, May 18, 2026. Reported Earnings • Mar 26
Full year 2025 earnings released: EPS: US$0.097 (vs US$0.054 in FY 2024) Full year 2025 results: EPS: US$0.097 (up from US$0.054 in FY 2024). Revenue: US$400.6m (up 16% from FY 2024). Net income: US$37.0m (up 78% from FY 2024). Profit margin: 9.2% (up from 6.0% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 7% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to Rp11,150, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 35% over the past three years. Reported Earnings • Nov 04
Third quarter 2025 earnings released: EPS: US$0.03 (vs US$0.018 in 3Q 2024) Third quarter 2025 results: EPS: US$0.03 (up from US$0.018 in 3Q 2024). Revenue: US$106.9m (up 22% from 3Q 2024). Net income: US$11.5m (up 63% from 3Q 2024). Profit margin: 11% (up from 8.0% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Board Change • Oct 14
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Independent President Commissioner Erwin Sudjono was the last independent director to join the board, commencing their role in 2010. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • May 23
PT Unggul Indah Cahaya Tbk announces Annual dividend, payable on June 12, 2025 PT Unggul Indah Cahaya Tbk announced Annual dividend of IDR 448.0000 per share payable on June 12, 2025, ex-date on June 02, 2025 and record date on June 03, 2025. Announcement • Apr 14
PT Unggul Indah Cahaya Tbk, Annual General Meeting, May 20, 2025 PT Unggul Indah Cahaya Tbk, Annual General Meeting, May 20, 2025. Location: jakarta Indonesia Reported Earnings • Nov 02
Third quarter 2024 earnings released: EPS: US$0.018 (vs US$0.017 in 3Q 2023) Third quarter 2024 results: EPS: US$0.018 (up from US$0.017 in 3Q 2023). Revenue: US$87.8m (down 7.5% from 3Q 2023). Net income: US$7.03m (up 9.1% from 3Q 2023). Profit margin: 8.0% (up from 6.8% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Announcement • May 09
PT Unggul Indah Cahaya Tbk, Annual General Meeting, Jun 14, 2024 PT Unggul Indah Cahaya Tbk, Annual General Meeting, Jun 14, 2024. Reported Earnings • May 05
First quarter 2024 earnings released: EPS: US$0.013 (vs US$0.016 in 1Q 2023) First quarter 2024 results: EPS: US$0.013 (down from US$0.016 in 1Q 2023). Revenue: US$89.5m (up 2.4% from 1Q 2023). Net income: US$4.96m (down 19% from 1Q 2023). Profit margin: 5.5% (down from 7.0% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Reported Earnings • Apr 02
Full year 2023 earnings released: EPS: US$0.059 (vs US$0.10 in FY 2022) Full year 2023 results: EPS: US$0.059 (down from US$0.10 in FY 2022). Revenue: US$339.3m (down 18% from FY 2022). Net income: US$22.4m (down 42% from FY 2022). Profit margin: 6.6% (down from 9.3% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Reported Earnings • Aug 05
Second quarter 2023 earnings released: EPS: US$0.008 (vs US$0.037 in 2Q 2022) Second quarter 2023 results: EPS: US$0.008 (down from US$0.037 in 2Q 2022). Revenue: US$79.4m (down 29% from 2Q 2022). Net income: US$3.07m (down 78% from 2Q 2022). Profit margin: 3.9% (down from 13% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 23
PT Unggul Indah Cahaya Tbk, Annual General Meeting, Jun 13, 2023 PT Unggul Indah Cahaya Tbk, Annual General Meeting, Jun 13, 2023, at 11:30 China Standard Time. Location: Hotel Indonesia Kempinski Heritage Room I, 16th Floor Jl. M.H. Thamrin No.1, Jakarta Indonesia Agenda: To consider and approve the Annual Report and Financial Statement for Financial Year 2022; to consider and approve the use of the Company's net profit for the financial year 2022; to consider the appointment of a Registered Public Accountant Firm that will audit the Company's Financial Statements for the financial year 2023; and to consider the determination of salaries, allowances and other facilities for the Board of Commissioners and Directors of the Company for the financial year 2023. Reported Earnings • May 06
First quarter 2023 earnings released: EPS: US$0.016 (vs US$0.04 in 1Q 2022) First quarter 2023 results: EPS: US$0.016 (down from US$0.04 in 1Q 2022). Revenue: US$87.4m (down 22% from 1Q 2022). Net income: US$6.15m (down 60% from 1Q 2022). Profit margin: 7.0% (down from 14% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 10 highly experienced directors. 1 independent director (3 non-independent directors). Independent Vice President Director Djazoeli Sadhani was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 10 highly experienced directors. 1 independent director (3 non-independent directors). Independent Vice President Director and Admin & General Affairs GM Djazoeli Sadhani was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Jan 04
Upcoming dividend of Rp450 per share Eligible shareholders must have bought the stock before 11 January 2022. Payment date: 27 January 2022. Payout ratio is a comfortable 7.5% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Indonesian dividend payers (3.9%). Higher than average of industry peers (1.1%). Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improved over the past week After last week's 15% share price gain to Rp12,900, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 36x in the Chemicals industry in Indonesia. Total returns to shareholders of 256% over the past three years. Reported Earnings • Nov 11
Third quarter 2021 earnings released: EPS US$0.037 (vs US$0.025 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$96.5m (up 19% from 3Q 2020). Net income: US$14.0m (up 46% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth. Reported Earnings • Sep 05
Second quarter 2021 earnings released: EPS US$0.04 (vs US$0.01 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$91.7m (up 21% from 2Q 2020). Net income: US$15.2m (up 286% from 2Q 2020). Profit margin: 17% (up from 5.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improved over the past week After last week's 19% share price gain to US$8,800, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total returns to shareholders of 198% over the past three years. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment improved over the past week After last week's 22% share price gain to US$6,100, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in Indonesia. Total returns to shareholders of 95% over the past three years. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$4,100, the stock is trading at a trailing P/E ratio of 5.9x, down from the previous P/E ratio of 7x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 40%. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment improved over the past week After last week's 23% share price gain to US$5,400, the stock is trading at a trailing P/E ratio of 7.7x, up from the previous P/E ratio of 6.3x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 92%. Reported Earnings • Dec 03
Third quarter 2020 earnings released: EPS US$0.026 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: US$81.1m (down 4.4% from 3Q 2019). Net income: US$9.62m (up 121% from 3Q 2019). Profit margin: 12% (up from 5.1% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 6% per year. Is New 90 Day High Low • Dec 03
New 90-day high: Rp4,290 The company is up 11% from its price of Rp3,850 on 03 September 2020. The Indonesian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 33% over the same period. Is New 90 Day High Low • Oct 07
New 90-day high: Rp3,950 The company is up 14% from its price of Rp3,450 on 09 July 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 4.0% over the same period. 
